These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7503755)

  • 1. Properties of the reversible K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. I. In vitro activity.
    Pope AJ; Boehm MK; Leach C; Ife RJ; Keeling D; Parsons ME
    Biochem Pharmacol; 1995 Nov; 50(10):1543-9. PubMed ID: 7503755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase.
    Keeling DJ; Malcolm RC; Laing SM; Ife RJ; Leach CA
    Biochem Pharmacol; 1991 Jun; 42(1):123-30. PubMed ID: 1648919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of the reversible, K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. II. Pharmacological properties.
    Parsons ME; Rushant B; Rasmussen TC; Leach C; Ife RJ; Postius S; Pope AJ
    Biochem Pharmacol; 1995 Nov; 50(10):1551-6. PubMed ID: 7503756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
    Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
    Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of AZD0865, a K+-competitive inhibitor of gastric H+,K+-ATPase.
    Gedda K; Briving C; Svensson K; Maxvall I; Andersson K
    Biochem Pharmacol; 2007 Jan; 73(2):198-205. PubMed ID: 17081503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soraprazan: setting new standards in inhibition of gastric acid secretion.
    Simon WA; Herrmann M; Klein T; Shin JM; Huber R; Senn-Bilfinger J; Postius S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):866-74. PubMed ID: 17369284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPase.
    Keeling DJ; Laing SM; Senn-Bilfinger J
    Biochem Pharmacol; 1988 Jun; 37(11):2231-6. PubMed ID: 2837231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the K+-competitive inhibitor site of gastric H,K-ATPase.
    Vagin O; Munson K; Lambrecht N; Karlish SJ; Sachs G
    Biochemistry; 2001 Jun; 40(25):7480-90. PubMed ID: 11412101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cibenzoline, an ATP-sensitive K(+) channel blocker, binds to the K(+)-binding site from the cytoplasmic side of gastric H(+),K(+)-ATPase.
    Tabuchi Y; Yashiro H; Hoshina S; Asano S; Takeguchi N
    Br J Pharmacol; 2001 Dec; 134(8):1655-62. PubMed ID: 11739241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hybrid between Na+,K+-ATPase and H+,K+-ATPase is sensitive to palytoxin, ouabain, and SCH 28080.
    Farley RA; Schreiber S; Wang SG; Scheiner-Bobis G
    J Biol Chem; 2001 Jan; 276(4):2608-15. PubMed ID: 11054424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A K+ competitive, conformational probe of the H,K-ATPase.
    Rabon EC; Sachs G; Leach CA; Keeling D
    Acta Physiol Scand Suppl; 1992; 607():269-73. PubMed ID: 1333158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody HK4001 completely inhibits K(+)-dependent ATP hydrolysis and H+ transport of hog gastric H+,K(+)-ATPase.
    Asano S; Tabuchi Y; Takeguchi N
    J Biochem; 1989 Dec; 106(6):1074-9. PubMed ID: 2560778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of stilbene derivatives on gastric H+, K(+)-ATPase.
    Murakami S; Arai I; Muramatsu M; Otomo S; Baba K; Kido T; Kozawa M
    Biochem Pharmacol; 1992 Nov; 44(10):1947-51. PubMed ID: 1333200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gastric H,K ATPase as a drug target: past, present, and future.
    Sachs G; Shin JM; Vagin O; Lambrecht N; Yakubov I; Munson K
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-.
    Cheon HG; Lim H; Lee DH
    Eur J Pharmacol; 2001 Jan; 411(1-2):181-186. PubMed ID: 11137874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic function of nongastric H,K-ATPase expressed in Sf-21 insect cells.
    Adams G; Tillekeratne M; Yu C; Pestov NB; Modyanov NN
    Biochemistry; 2001 May; 40(19):5765-76. PubMed ID: 11341842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible and potent uncoupling of hog gastric (H(+)+K(+))-ATPase by prodigiosins.
    Matsuya H; Okamoto M; Ochi T; Nishikawa A; Shimizu S; Kataoka T; Nagai K; Wasserman HH; Ohkuma S
    Biochem Pharmacol; 2000 Dec; 60(12):1855-63. PubMed ID: 11108801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible inhibitors of the gastric (H+/K+)-ATPase. 2. 1-Arylpyrrolo[3,2-c]quinolines: effect of the 4-substituent.
    Leach CA; Brown TH; Ife RJ; Keeling DJ; Laing SM; Parsons ME; Price CA; Wiggall KJ
    J Med Chem; 1992 May; 35(10):1845-52. PubMed ID: 1316968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of gastric H+, K(+)-ATPase by quercetin.
    Murakami S; Muramatsu M; Otomo S
    J Enzyme Inhib; 1992; 5(4):293-8. PubMed ID: 1285250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands.
    Kirchhoff P; Andersson K; Socrates T; Sidani S; Kosiek O; Geibel JP
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G838-43. PubMed ID: 16798725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.